# Comparison Study of PET/CT or PET/MRI Imaging to Magnetic Resonance Imaging (MRI) Alone in Men With Prostate Cancer

> **NCT03439033** · PHASE2 · TERMINATED · sponsor: **Weill Medical College of Cornell University** · enrollment: 273 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** PET/MRI with Gallium-68 labeled PSMA-HBED-CC
- **DRUG:** Multiple PET/MRI with Gallium-68 labeled PSMA-HBED-CC
- **DRUG:** PET/CT with Gallium-68 labeled PSMA-HBED-CC

## Key facts

- **NCT ID:** NCT03439033
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-04-03
- **Primary completion:** 2021-05-05
- **Final completion:** 2021-05-05
- **Target enrollment:** 273 (ACTUAL)
- **Why stopped:** Study Drug was FDA approved Summer 2021
- **Last updated:** 2023-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03439033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03439033, "Comparison Study of PET/CT or PET/MRI Imaging to Magnetic Resonance Imaging (MRI) Alone in Men With Prostate Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03439033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*